Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives.

M Angeles Solinís , Yaimy de la Cruz , Begoña Calvo , Rosa M Hernández
Chirality 14 ( 10) 806 -813

14
2002
New gene delivery system based on oligochitosan and solid lipid nanoparticles: 'in vitro' and 'in vivo' evaluation.

Diego Delgado , Ana del Pozo-Rodríguez , M. Angeles Solinís , Artur Bartkowiak
European Journal of Pharmaceutical Sciences 50 ( 50) 484 -491

42
2013
Silencing of hepatitis C virus replication by a non-viral vector based on solid lipid nanoparticles containing a shRNA targeted to the internal ribosome entry site (IRES)

Josune Torrecilla , Ana del Pozo-Rodríguez , María ÿngeles Solinís , Paola S. Apaolaza
Colloids and Surfaces B: Biointerfaces 146 808 -817

14
2016
A proposal to prevent omissions and delays of antiparkinsonian drug administration in hospitals.

Unax Lertxundi , Arantxazu Isla , Ma Angeles Solinis , Saioa Domingo-Echaburu
The Neurohospitalist 5 ( 2) 53 -54

4
2015
Pharmacokinetics of spironolactone formulated as nanostructured lipid carriers

Ana Beloqui Garcia , MA Solinis , AR Gascon , A Isla
III conference on Modeling and Simulation in Biomedicine

2009
Vaginal gene therapy.

Alicia Rodríguez-Gascón , Ana del Pozo-Rodríguez , Arantxazu Isla , María Angeles Solinís
Advanced Drug Delivery Reviews 92 71 -83

19
2015
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles

Alicia Rodriguez-Gascon , Ana del Pozo-Rodríguez , María Angeles Solinís
International Journal of Nanomedicine 9 ( 1) 1833 -1843

41
2014
Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology

Arantxazu Isla , Andrés Canut , Alicia Rodríguez-Gascón , Alicia Labora
Enfermedades Infecciosas y Microbiologia Clinica 23 ( 3) 116 -121

15
2005
Gene delivery in the cornea: in vitro and ex vivo evaluation of solid lipid

Mónica Vicente-Pascual , Andrea Albano , María Angeles Solinís , Loredana Serpe

Solid Lipid Nanoparticles as Non-Viral Vectors for Gene Transfection in a Cell Model of Fabry Disease.

A. P. Ruiz de Garibay , M. A. Solinís , A. del Pozo-Rodríguez , P. S. Apaolaza
Journal of Biomedical Nanotechnology 11 ( 3) 500 -511

9
2015
Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration.

Ana del Pozo-Rodríguez , Diego Delgado , Maria Ángeles Solinís , Jose Luis Pedraz
International Journal of Pharmaceutics 385 ( 1) 157 -162

60
2010
Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice.

Diego Delgado , Alicia Rodríguez Gascón , Ana del Pozo-Rodríguez , Enrique Echevarría
International Journal of Pharmaceutics 425 ( 1) 35 -43

57
2012
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina

Ana del Pozo-Rodríguez , Diego Delgado , Alicia R Gascón , Maria Ángeles Solinís
Journal of Ocular Pharmacology and Therapeutics 29 ( 2) 173 -188

62
2013
Dextran and Protamine-Based Solid Lipid Nanoparticles as Potential Vectors for the Treatment of X-Linked Juvenile Retinoschisis

Diego Delgado San Vicente , Ana Del Pozo Rodríguez , María Ángeles Solinís Aspiazu , Marcelino Avilés Triqueros
Human Gene Therapy 23 ( 4) 345 -355

56
2012
In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.

Lourdes Ochoa , Manoli Igartua , Rosa M Hernández , Maria Ángeles Solinís
European Journal of Pharmaceutics and Biopharmaceutics 75 ( 2) 232 -237

18
2010
Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway

Diego Delgado , Ana del Pozo-Rodríguez , Maria Ángeles Solinís , Alicia Rodríguez-Gascón
European Journal of Pharmaceutics and Biopharmaceutics 79 ( 3) 495 -502

69
2011
Application of lipid nanoparticles to ocular drug delivery

Luigi Battaglia , Loredana Serpe , Federica Foglietta , Elisabetta Muntoni
Expert Opinion on Drug Delivery 13 ( 12) 1743 -1757

121
2016
Anticholinergic burden in Parkinson's disease inpatients.

Unax Lertxundi , Arantxazu Isla , Maria Angeles Solinis , Saioa Domingo-Echaburu
European Journal of Clinical Pharmacology 71 ( 10) 1271 -1277

14
2015